These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 8390871)
21. Gonadotropin-releasing hormone (GnRH)-binding sites in human breast cancer cell lines and inhibitory effects of GnRH antagonists. Eidne KA; Flanagan CA; Harris NS; Millar RP J Clin Endocrinol Metab; 1987 Mar; 64(3):425-32. PubMed ID: 3029154 [TBL] [Abstract][Full Text] [Related]
22. Gonadotropin-releasing hormone analog buserelin causes neuronal loss in rat gastrointestinal tract. Sand E; Voss U; Hammar O; Alm R; Fredrikson GN; Ohlsson B; Ekblad E Cell Tissue Res; 2013 Mar; 351(3):521-34. PubMed ID: 23254679 [TBL] [Abstract][Full Text] [Related]
23. Effect of gonadotropin-releasing hormone agonists, nafarelin, buserelin, and leuprolide, on experimentally induced endometriosis in the rat. Mizutani T; Sakata M; Terakawa N Int J Fertil Menopausal Stud; 1995; 40(2):106-11. PubMed ID: 7599657 [TBL] [Abstract][Full Text] [Related]
24. Is there a difference in the function of granulosa-luteal cells in patients undergoing in-vitro fertilization either with gonadotrophin-releasing hormone agonist or gonadotrophin-releasing hormone antagonist? Lin Y; Kahn JA; Hillensjö T Hum Reprod; 1999 Apr; 14(4):885-8. PubMed ID: 10221213 [TBL] [Abstract][Full Text] [Related]
25. Signaling and antiproliferative effects of type I and II gonadotropin-releasing hormone receptors in breast cancer cells. Finch AR; Green L; Hislop JN; Kelly E; McArdle CA J Clin Endocrinol Metab; 2004 Apr; 89(4):1823-32. PubMed ID: 15070951 [TBL] [Abstract][Full Text] [Related]
26. Regulation of G(q/11)alpha by the gonadotropin-releasing hormone receptor. Stanislaus D; Janovick JA; Brothers S; Conn PM Mol Endocrinol; 1997 Jun; 11(6):738-46. PubMed ID: 9171237 [TBL] [Abstract][Full Text] [Related]
27. Signaling and antiproliferative effects mediated by GnRH receptors after expression in breast cancer cells using recombinant adenovirus. Everest HM; Hislop JN; Harding T; Uney JB; Flynn A; Millar RP; McArdle CA Endocrinology; 2001 Nov; 142(11):4663-72. PubMed ID: 11606431 [TBL] [Abstract][Full Text] [Related]
28. Gonadotropin-releasing hormone neuropeptides and receptor in human breast cancer: correlation to poor prognosis parameters. Pazaitou-Panayiotou K; Chemonidou C; Poupi A; Koureta M; Kaprara A; Lambropoulou M; Constantinidis TC; Galaktidou G; Koffa M; Kiziridou A; Kakolyris S; Kolios G; Kortsaris A; Chatzaki E Peptides; 2013 Apr; 42():15-24. PubMed ID: 23287110 [TBL] [Abstract][Full Text] [Related]
29. Human placental GnRH-like factors: parallel displacement in GnRH immuno- and receptor-binding assays can be caused by degradation of radiolabelled GnRH tracers. Bramley TA; Boyle HP; Menzies GS Mol Hum Reprod; 1999 Dec; 5(12):1095-106. PubMed ID: 10587363 [TBL] [Abstract][Full Text] [Related]
30. Prenatal development of gonadotropin-releasing hormone receptors in the rat anterior pituitary. Jennes L Endocrinology; 1990 Feb; 126(2):942-7. PubMed ID: 2153535 [TBL] [Abstract][Full Text] [Related]
31. Characterization of GnRH receptors in bovine pituitary membranes. Hazum E; Keinan D Mol Cell Endocrinol; 1984 May; 35(2-3):107-11. PubMed ID: 6329848 [TBL] [Abstract][Full Text] [Related]
32. Comparative analysis of different puberty inhibiting mechanisms of two GnRH agonists and the GnRH antagonist cetrorelix using a female rat model. Roth C; Leonhardt S; Seidel C; Luft H; Wuttke W; Jarry H Pediatr Res; 2000 Oct; 48(4):468-74. PubMed ID: 11004237 [TBL] [Abstract][Full Text] [Related]
33. Testicular GnRH-receptors and direct effects of a GnRH-agonist on human testicular steroidogenesis. Petersson F; Emons G; Hammar M Scand J Urol Nephrol; 1989; 23(3):161-4. PubMed ID: 2552570 [TBL] [Abstract][Full Text] [Related]
35. Signalling and anti-proliferative effects mediated by gonadotrophin-releasing hormone receptors after expression in prostate cancer cells using recombinant adenovirus. Franklin J; Hislop J; Flynn A; McArdle CA J Endocrinol; 2003 Feb; 176(2):275-84. PubMed ID: 12553876 [TBL] [Abstract][Full Text] [Related]
36. Addition of catfish gonadotropin-releasing hormone (GnRH) receptor intracellular carboxyl-terminal tail to rat GnRH receptor alters receptor expression and regulation. Lin X; Janovick JA; Brothers S; Blömenrohr M; Bogerd J; Conn PM Mol Endocrinol; 1998 Feb; 12(2):161-71. PubMed ID: 9482659 [TBL] [Abstract][Full Text] [Related]
37. Treatment of breast cancer with gonadotropin-releasing hormone. Manni A; Santen R; Harvey H; Lipton A; Max D Endocr Rev; 1986 Feb; 7(1):89-94. PubMed ID: 3082618 [TBL] [Abstract][Full Text] [Related]
38. Combined modification of intracellular and extracellular loci on human gonadotropin-releasing hormone receptor provides a mechanism for enhanced expression. Maya-Núñez G; Janovick JA; Conn PM Endocrine; 2000 Dec; 13(3):401-7. PubMed ID: 11216654 [TBL] [Abstract][Full Text] [Related]
39. In vivo regulation of granulosa cell type I insulin-like growth factor receptors: evidence for an inhibitory role for the putative endogenous ligand(s) of the ovarian gonadotropin-releasing hormone receptor. Adashi EY; Resnick CE; Vera A; Hernandez ER Endocrinology; 1991 Jun; 128(6):3130-7. PubMed ID: 1645262 [TBL] [Abstract][Full Text] [Related]
40. Tunicamycin and neuraminidase effects on luteinizing hormone (LH)-releasing hormone binding and LH release from rat pituitary cells in culture. Schvartz I; Hazum E Endocrinology; 1985 Jun; 116(6):2341-6. PubMed ID: 2986947 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]